panelarrow

Publications

BOOKS

  • Joint Author, Emergencies in Gastroenterology & Hepatology (OUP) (published August 2013)
  • Gastroenterology & Hepatology chapter co-editor, Oxford Desk Reference: Acute Medicine (OUP, published 2016)

PAPERS

  • Third European Evidence-Based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders.
    Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, Burisch J, Gecse KB, Hart AL, Hindryckx P, Langner C, Limdi JK, Pellino G, Zagórowicz E, Raine T, Harbord M, Rieder F; European Crohn’s and Colitis Organisation (ECCO).
    J Crohns Colitis. 2017 Feb 2. doi: 10.1093/ecco-jcc/jjx008
  • Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
    Marcus Harbord, Rami Eliakim, Dominik Bettenworth, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Torsten Kucharzik, Tamás Molnár, Tim Raine, Shaji Sebastian, Helena Tavares de Sousa, Axel Dignass, Franck Carbonnel; for the European Crohn’s and Colitis Organisation [ECCO]
    J Crohns Colitis. 2017
  • European Crohn’s and Colitis Organisation Topical Review on Transitional Care in Inflammatory Bowel Disease.
    van Rheenen PF, Aloi M, Biron IA, Carlsen K, Cooney R, Cucchiara S, Cullen G, Escher J, Kierkus J, Lindsay JO, Roma E, Russell RK, Sieczkowska-Golub J, Harbord M.
    J Crohns Colitis. 2017 Feb 2. doi: 10.1093/ecco-jcc/jjx010.
  • 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management.
    Gomollón F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, Peyrin-Biroulet L, Cullen GJ, Daperno M, Kucharzik T, Rieder F, Almer S, Armuzzi A, Harbord M, Langhorst J, Sans M, Chowers Y, Fiorino G, Juillerat P, Mantzaris GJ, Rizzello F, Vavricka S, Gionchetti P; ECCO.
    J Crohns Colitis. 2017 Jan;11(1):3-25
  • A Systematic Review Assessing Medical Treatment for Rectovaginal and Enterovesical Fistulae in Crohn’s Disease.
    Kaimakliotis P, Simillis C, Harbord M, Kontovounisios C, Rasheed S, Tekkis PP.
    J Clin Gastroenterol. 2016 Oct;50(9):714-21
  • Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong.
    Ng SC, Leung WK, Shi HY, Li MK, Leung CM, Ng CK, Lo FH, Hui YT, Tsang SW, Chan YK, Loo CK, Chan KH, Hui AJ, Chow WH, Harbord M, Ching JY, Lee M, Chan V, Tang W, Hung IF, Ho J, Lao WC, Wong MT, Sze SF, Shan EH, Lam BC, Tong RW, Mak LY, Wong SH, Wu JC, Chan FK, Sung JJ.
    Inflamm Bowel Dis. 2016 Aug;22(8):1954-60
  • Low-dose azathioprine is effective in maintaining remission in steroid-dependent ulcerative colitis: results from a territory-wide Chinese population-based IBD registry.
    Shi HY, Chan FK, Leung WK, Li MK, Leung CM, Sze SF, Ching JY, Lo FH, Tsang SW, Shan EH, Mak LY, Lam BC, Hui AJ, Chow WH, Wong MT, Hung IF, Hui YT, Chan YK, Chan KH, Loo CK, Ng CK, Lao WC, Harbord M, Wu JC, Sung JJ, Ng SC.
    Therap Adv Gastroenterol. 2016 Jul;9(4):449-56
  • Danish cohort of monozygotic inflammatory bowel disease twins: Clinical characteristics and inflammatory activity.
    Moller FT, Knudsen L, Harbord M, Satsangi J, Gordon H, Christiansen L, Christensen K, Jess T, Andersen V.
    World J Gastroenterol. 2016 Jun 7;22(21):5050-9
  • Percutaneous gastrostomy: troubleshooting complications.
    Lepore M, Marks DJ, Harbord MW.
    Br J Hosp Med (Lond). 2016 Jun;77(6):C86-90
  • Dysregulated Lysine Acetyltransferase 2B Promotes Inflammatory Bowel Disease Pathogenesis Through Transcriptional Repression of Interleukin-10.
    Bai AH, Wu WK, Xu L, Wong SH, Go MY, Chan AW, Harbord M, Zhang S, Chen M, Wu JC, Chan MW, Chan MT, Chan FK, Sung JJ, Yu J, Cheng AS, Ng SC.
    J Crohns Colitis. 2016 Jun;10(6):726-34
  • Why I don’t want to continue practising general medicine and delivering the acute ‘take’
    Marcus Harbord
    Future Hospital Journal 2016 Vol 3, No 1: 70–1
  • Natural History of Elderly-onset Ulcerative Colitis: Results from a Territory-wide Inflammatory Bowel Disease Registry.
    Shi HY, Chan FK, Leung WK, Li MK, Leung CM, Sze SF, Ching JY, Lo FH, Tsang SW, Shan EH, Mak LY, Lam BC, Hui AJ, Wong SH, Wong MT, Hung IF, Hui YT, Chan YK, Chan KH, Loo CK, Tong RW, Chow WH, Ng CK, Lao WC, Harbord M, Wu JC, Sung JJ, Ng SC.
    J Crohns Colitis. 2016 Feb;10(2):176-85.
  • The First European Evidence-Based Consensus on Extra-Intestinal Manifestations in Inflammatory Bowel Disease
    Marcus Harbord; Vito Annese; Stephan R. Vavricka; et al.
    Journal of Crohn’s and Colitis 2016 Mar;10(3):239-54
  • Heritability in inflammatory bowel disease – from the first twin study to GWAS
    Gordon H, Trier Moller F, Andersen V, Harbord M.
    Inflamm Bowel Dis. 2015 Jun;21(6):1428-34
  • Management of cirrhotic ascites
    Bashyam M, Lepore M, Harbord M
    Br J Hosp Med 2015 Feb; 76(2):C28-32
  • A patient with severe Crohn’s colitis responds to Faecal Microbiota Transplantation.
    Gordon H, Harbord M.
    J Crohns Colitis. 2014 Mar;8(3):256-7
  • Non-colorectal intestinal tract carcinomas in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (II).
    Egan L, D’Inca R, Jess T, Pellino G, Carbonnel F, Bokemeyer B, Harbord M, Nunes P, Van der Woude J, Selvaggi F, Triantafillidis J.
    J Crohns Colitis. 2014 Jan;8(1):19-30
  • Ustekinumab induction and maintenance therapy in refractory Crohn’s disease.
    Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG; CERTIFI Study Group.
    N Engl J Med. 2012 Oct 18;367(16):1519-28
  • Marcus Harbord & Suzanne Pomfret, Nausea and vomiting, Medicine 2013; 41:87-91
  • Lotte Dinesen & Marcus Harbord, Acute diarrhoea, Medicine 2013; 104-107
  • Editor, CME Gastroenterology
    Clin Med 2012; 12(6):572-595
  • Hendy P, Patel J, Kordbacheh T, Laskar N and Harbord M
    Delays in Discharge: A metropolitan teaching hospital experience
    Clin Med 2012; 12(4):320-323
  • Patel, K and Harbord, M
    Digital dictation and voice transcription software enhances out-patient clinic letter production: a cross-over study.
    Frontline Gastroenterology, 2012; 3:162-165
  • Siew C. Ng, Susannah Woodrow, Nisha Patel, Javaid Subhani, Marcus Harbord
    The Role of Genetic and Environmental Factors In British Twins with Inflammatory Bowel Disease
    Inflammatory Bowel Disease, 2012 Apr; 18(4):725-36
  • Chowers Y, Sturm A, Sans M,  Papadakis K, Gazouli M, Harbord M, Jahnel  J, Mantzaris GJ, Meier J, Mottet C, Peyrin- Biroulet L, Allez M.
    Report of the ECCO workshop on anti-TNF  therapy failures in inflammatory bowel diseases:  biological roles and effects of TNF and TNF  antagonists.
    J Crohns Colitis. 2010  Oct;4(4):367-76.
  • Hall, M., Clarke S et al, (2010) Annual Evidence Update on Inflammatory Bowel Disease, NLHSpecialist Library for Gastroenterology and Liver Diseases, available online at http://www.library.nhs.uk/gastroliver/viewResource.aspx?resID=346211
  • Clarke S et al, (2009). Annual Evidence Update on Inflammatory Bowel Disease, NLHSpecialist Library for Gastroenterology and Liver Diseases, available online at www.library.nhs.uk/gastroliver/
  • Marcus Harbord, Nausea and vomiting, Medicine 2008; 37:2 115-118
  • Chua I, Standish R, Lear S, Harbord M, Eren E, Raeiszadeh M, Workman S, Webster D.
    Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID).
    Clin Exp Immunol. 2007 Nov;150(2):306-11
  • M Epstein, N Barmania, J Robin, M.W.N.Harbord
    Improving the patient journey
    Clin Med 2007; 7(4):343-347
  • M.W.N.Harbord, D.J.B.Marks, A. Forbes, S.Bloom, R.M.Day, A.W.Segal
    Impaired neutrophil chemotaxis in Crohn’s disease relates to reduced production of chemokines and can be augmented by G-CSF
    Aliment. Pharmacol. Ther. 2006; 24:651-660
  • D.J.B.Marks, M.W.N.Harbord, R.MacAllister, F.Z.Rahman, J.Young, B.Al-Lazikani, W.Lees, M.Novelli, S.Bloom, A.W.Segal
    Defective acute inflammation in Crohn’s disease: a clinical investigation
    Lancet 2006; 367:668-678
  • A.R.Schenkel, T.W.Chew, M.Harbord, W.A.Muller
    Different susceptibilities to spontaneous idiopathic pneumonitis in PECAM deficient mouse strains
    Experimental and Molecular Pathology, 2006; 81(1):23-30
  • N.A. Mitchison, M. Harbord, A. Hankin, J. Roes
    Conditional haploinsufficiency of NCF1, a signalling gene with a heterozygous phenotype potentially subject to natural selection
    Immunology Letters 2005; 97:63-67
  • N. Suraweera, E. Zampeli, P. Rogers, W. Atkin, A. Forbes, M. Harbord, A. Silver
    NCF1 (p47phox) and ncf1 pseudogenes are not associated with inflammatory bowel disease
    Inflamm Bowel Dis. 2004 Nov;10(6):758-62
  • M. Harbord, A. Hankin, S. Bloom, H. Mitchison
    Association between p47phox pseudogenes and inflammatory bowel disease
    Blood 2003; 101(8):3337
  • Plenary poster presentation at the British Society of Gastroenterology 2003 & at the 3rd International Inflammatory Bowel Disease Meeting, Chester, UK (Aliment Pharmacol Ther 2003; 17(4))
  • M. Harbord, R. Dawes, H. Barr, M. Giovannini, P. Viens, V. Eysselein, L. Mishra, E. Orenberg, S. Bown
    Palliation of dysphagia in advanced esophageal cancer by endoscopic injection of cisplatin/epinephrine injectable gel
    Gastrointestinal Endoscopy 2002; 56(5):644-651
  • M. Harbord, M. Novelli, B. Canas, D. Power, C. Davis, J. Godovac-Zimmermann, J. Roes, A.W. Segal
    Ym1 is a neutrophil granule protein that crystallizes in p47phox deficient mice
    J Biol Chem 2002; 277(7): 5468-5475
    Presented at the European Society for Clinical Investigation (Eur. J. Clin. Invest. 2001; 31(Suppl. 1): A174)
  • H. Tiwana, R.S. Natt, R. Benitez-Brito, S. Shah, C. Wilson, S. Bridger, M. Harbord, M. Sarner, A. Ebringer
    Correlation between the immune responses to collagens type I, III, IV and V and Klebsiella pneumoniae in patients with Crohn’s disease and ankylosing spondylitis
    Rheumatology 2001; 40(1): 15-23
  • R. Day, M. Harbord, A. Forbes, A.W.Segal
    Cantharidin Blisters : A technique for investigating leukocyte trafficking and cytokine production at sites of inflammation in humans
    J. Immunol. Methods 2001; 257: 213-220
  • M. Harbord, S Ivanova, N Akhtar, Y Gupta
    Waldenström macroglobulinaemia presenting as bleeding diathesis with paradoxical coagulation of blood samples
    J. Acc. & Emer. Med. 1998; 15(5): 331
  • K. Besherdas, A. Leahy, I. Mason, M. Harbord, O. Epstein
    The effect of cisapride on dyspepsia symptoms and the electrogastrogram in patients with non-ulcer dyspepsia
    Aliment. Pharmacol. Ther. 1998; 12: 755-759
  • A.Bonnington, M.Harbord, R.Davidson, R.Behrens
    Immunisation against Japanese encephalitis
    Lancet 1995; 345: 1445-1446

ELECTRONIC MEDIA

  • Owen Epstein & Marcus Harbord
    Answers in Gastroenterology, Educational CD. Published by Answers in Medicine, 2008
  • M. Harbord, I. Mason, J. Bowles, J. Linehan, O. Epstein
    How to use suppositories, foams and enemas in colitis
    Gut 1999; 44(1): 576V
    (Second prize, B.S.G. video competition 1999)
  • M. Harbord, G. Webster, J. Linehan, O. Epstein
    Interactive Gastro-Endoscopy CD-Rom
    Gut 1999; 44(1): 579V
    (CD-ROM Special Prize, B.S.G. video competition 1999)